The effect of selenium on immunogenicity of influenza vaccine in the elderly: A case-control double-blinded clinical trial

Author(s):
Alireza  JanbakhshAlireza Janbakhsh1,*, Feizollah MansouriFeizollah Mansouri1, Siavash VaziriSiavash Vaziri1, Babak SayadBabak Sayad1, Mandana AfsharianMandana Afsharian1, Mansour RezaeiMansour Rezaei2, Sohrab HeidariSohrab Heidari1
1Department of Infectious Diseases, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
2Department of Biostatistics and Epidemiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
*Corresponding Author: Corresponding author: Alireza Janbakhsh, Department of Infectious Diseases, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran, Tel: +98 8334276315 Email: [email protected]

Journal of Kermanshah University of Medical Sciences:Vol. 20, issue 1; e69746
Published online:Jun 19, 2016
Article type:Research Article
Received:May 09, 2016
Accepted:Jun 14, 2016
How to Cite:Janbakhsh A, Mansouri F, Vaziri S, Sayad B, Afsharian M, et al. The effect of selenium on immunogenicity of influenza vaccine in the elderly: A case-control double-blinded clinical trial. J Kermanshah Univ Med Sci. 2016;20(1):e69746. doi: https://doi.org/10.22110/jkums.v20i1.3122

Abstract

Introduction: Influenza can cause more severe diseases and higher rate of morbidity and mortality in the elderly population. Therefore, they should receive influenza vaccine annually. However, the host response to vaccine is less in older individuals. On the other hand, selenium can act as a stimulator of the immune system and cause increased immunity and response to vaccine. This study was carried out to determine the effect of selenium on antibody production against influenza vaccine. By verifying this effect, selenium can be recommended as an adjuvant therapy in the elderly.

Methods: A total of 110 subjects were selected at Infectious Diseases Research Center of Imam Reza Hospital in Kermanshah. They were divided into two groups of adjuvant (N=56) and placebo (N=54). The adjuvant group received influenza vaccine and selenium tablet. The placebo group received influenza vaccine and placebo tablet. Venous blood samples were taken before and four weeks after vaccination and the results were compared between the two groups.

Results: Seroconversion, seroprotection, and geometric mean titer (GMT) for three strains (H1N1, H3N2, and B) were assessed. The seroconversion and GMT rates against influenza B vaccine component were significantly higher in adjuvant group than placebo group.

Conclusion: Considering the ability of selenium in induction of a better response to influenza vaccine in older people as well as its low cost and accessibility, selenium can be used to increase antibody level in such cases.

Fulltext

References

  • 1.
    The references of this article is available on PDF.

Copyright

© 2016, Journal of Kermanshah University of Medical Sciences. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

19
Mar
2019

Seasonal Influenza Vaccination Uptake and Its Socioeconomic Determinants in Patients and Staff of Hospitals in Shahroud, Northeast of Iran

Roqayeh Aliyari,
Shakiba Imani,
Tooba Rezaiy,
Mohammad Shariati,
Parastoo Hanifehzad Masooleh,
Seyed Mohammad Mirrezaie

Aliyari R, Imani S, Rezaiy T, Shariati M, Hanifehzad Masooleh P, et al. Seasonal Influenza Vaccination Uptake and Its Socioeconomic Determinants in Patients and Staff of Hospitals in Shahroud, Northeast of Iran. Shiraz E-Med J. 2019;20(4):e82898. doi: https://doi.org/10.5812/semj.82898

26
Jun
2016

Seasonal Influenza and Prevention

Batool Sharifi Mood,
Farnoosh Sharifi Mood,
Roshanak Sharifi

Sharifi Mood B, Sharifi Mood F, Sharifi R. Seasonal Influenza and Prevention. Int J Infect. 2016;3(4):e35954. doi: https://doi.org/10.17795/iji-35954

25
Sep
2023
Arch Clin Infect Dis

Safety and Efficacy of Selenium on Recovery of Hospitalized Patients with COVID-19: A Randomized Controlled Clinical Trial

Elham Shafiei,
Golnaz Mahmoudvand,
Arian Karimi Rouzbahani,
Ali Nazari

Shafiei E, Mahmoudvand G, Karimi Rouzbahani A, Nazari A. Safety and Efficacy of Selenium on Recovery of Hospitalized Patients with COVID-19: A Randomized Controlled Clinical Trial. Arch Clin Infect Dis. 2023;18(4):e137390. doi: https://doi.org/10.5812/archcid-137390

10
Mar
2015

The Effect of Selenium Supplementation on Acute Phase Reactants and Thyroid Function Tests in Hemodialysis Patients

Hamid Reza Omrani,
Mehrali Rahimi,
Kanan Nikseresht

Omrani HR, Rahimi M, Nikseresht K. The Effect of Selenium Supplementation on Acute Phase Reactants and Thyroid Function Tests in Hemodialysis Patients. Nephro-Urol Mon. 2015;7(2):e24781. doi: https://doi.org/10.5812/numonthly.24781

25
May
2025
Inn J Pediatr

Serum Selenium Levels in Children and Adolescents with Autoimmune Thyroiditis; Low-Dose, Short-Term Selenium Supplementation Effects

Lütfiye İdil Emral,
Ayça Törel Ergür

Emral Lİ, Törel Ergür A. Serum Selenium Levels in Children and Adolescents with Autoimmune Thyroiditis; Low-Dose, Short-Term Selenium Supplementation Effects. Inn J Pediatr. 2025;35(3):e158009. doi: https://doi.org/10.5812/ijpediatr-158009

Download PDF178.80 KB

Crossmark

Crossmark

Checking

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles